Shengtai Pharmaceutical, Inc. (SGTI) Return on Investment ROI from the third quarter of 2013 to third quarter of 2012 and for the year 2013, average high and low, overall ranking from Mar 31 2013 to Mar 31 2012 - CSIMarket
CSIMarket
 


Shengtai Pharmaceutical, Inc.  (SGTI)


Shengtai Pharmaceutical,'s ROI from its third quarter of 2013 to the third quarter of 2012 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Shengtai Pharmaceutical,'s ROI in the third quarter of 2013?
Shengtai Pharmaceutical, Inc. achieved a return on average invested assets (ROI) of 0.89 % in its third quarter of 2013, this is above SGTI's average return on investment of 0%.
Shengtai Pharmaceutical, Inc. invested over the 12 months ending in its third quarter of 2013 $63 million

Within the Healthcare sector Shengtai Pharmaceutical, Inc. achieved the highest return on investment. While the total ranking for ROI remained the same, compared to the second quarter of 2013 at no. .

Definition and Formula of Return on Investment



Return On Investment (Mar 31 2013)
III. Quarter
(Dec 31 2012)
II. Quarter
(Sep 30 2012)
I. Quarter
(Jun 30 2012)
IV. Quarter
(Mar 31 2012)
III. Quarter
Y / Y Investment Change TTM 3.65 % 37.91 % 105.82 % 313.96 % -
Y / Y Net Income Change TTM -87.13 % -91.55 % -96.55 % -84.09 % 89.69 %
Investment (TTM) in Millions 64 64 62 62 62
Return On Investment (TTM) 0.89 % 0.89 % 0.37 % 1.49 % 7.17 %
SGTI's Overall Ranking # # # # #
Seq. Investment Change TTM 0.84 % 1.07 % 0.58 % 1.11 % 34.17 %
Seq. Net Income Change TTM 1.24 % 142.19 % -74.97 % -79.03 % -33.54 %
Net Income (TTM) in Millions 1 1 0 1 4




Return On Investment SGTI's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Shengtai Pharmaceutical,'s III. Quarter Investments $ 64 Millions SGTI's Balance sheet
Shengtai Pharmaceutical,'s III. Quarter Income $ 0 Millions Quarterly SGTI's Income Statement
SGTI's Income by Division See SGTI's Income by Division


SGTI Annual Return On Investment (Jun 30 2012)
2012




Total Investments in Millions 62 0 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions 1 0 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 1.72 % - - - -


Annual Roi Comment
In the fiscal year 2012 ROI improved to 1.72 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SGTI's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SGTI's Competitors
Subscribers only: Roi for Shengtai Pharmaceutical,'s Suppliers
Subscribers only: Return On Investment for SGTI's Customers

Other Ratios
SGTI's Roa SGTI's Inventory Turnover Ratio SGTI's Growth Rates SGTI's Dividend Statistics
SGTI's Profitability Ratios SGTI's Asset Turnover Ratio SGTI's Dividend Growth
SGTI's Roe SGTI's Valuation Ratios SGTI's Financial Strength Ratios SGTI's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2013, within Healthcare Sector ROI
Luminex Corporation  2.42 %
Natus Medical Inc  2.37 %
Integra Lifesciences Holdings Corp  2.07 %
Alkermes Plc   1.85 %
Enovis Corp  1.80 %
Biocept Inc   1.77 %
Harvard Bioscience Inc   1.59 %
Immucell Corporation  1.33 %
American Shared Hospital Services  1.20 %
Cumberland Pharmaceuticals Inc   1.14 %
Tivity Health Inc   1.10 %
Wright Medical Group N v   1.00 %
Bausch Health Companies Inc   0.66 %
Viskase Holdings inc   0.51 %
Heska Corporation  0.41 %
Nuvasive Inc  0.26 %
Tenet Healthcare Corp  0.21 %
Masimo Corp  0.21 %


Date modified: 2026-09-08T15:21:55+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.